Emma Ristori

Dr. Emma Ristori

University of Siena
+2
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
TBTanyeri Barak
Tanyeri Barak
EREmma Ristori
Emma Ristori
AEA. Gulhan Ercan-Sencicek
A. Gulhan Ercan-Sencicek
DMDanielle F. Miyagishima
Danielle F. Miyagishima
CNCarol Nelson-Williams
Carol Nelson-Williams
MGMurat Günel
Murat Günel

1 March 2017 in Developmental Cell
Verified
Journal Article
Closed access
DKDionna M. Kasper
Dionna M. Kasper
AMAlbertomaria Moro
Albertomaria Moro
EREmma Ristori
Emma Ristori
ANAnand Narayanan
Anand Narayanan
GHGuillermina Hill-Teran
Guillermina Hill-Teran
SNStefania Nicoli
Stefania Nicoli

3 August 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Patrizia HRELIAPatrizia HRELIA
Patrizia HRELIA
GSGiulia Sita
Giulia Sita
MZMarina Ziche
Marina Ziche
EREmma Ristori
Emma Ristori
Angela MarinoAngela Marino
Angela Marino
Silvana HreliaSilvana Hrelia
Silvana Hrelia
Neurodegenerative disease is an umbrella term for different conditions which primarily affect the neurons in the human brain. In the last century, significant research has been focused on mechanisms and risk factors relevant to the multifaceted etiopathogenesis of neurodegenerative diseases. Currently, neurodegenerative diseases are incurable, and the treatments available only control the symptoms or delay the progression of the disease. This review is aimed at characterizing the complex network of molecular mechanisms underpinning acute and chronic neurodegeneration, focusing on the disturbance in redox homeostasis, as a common mechanism behind five pivotal risk factors: aging, oxidative stress, inflammation, glycation, and vascular injury. Considering the complex multifactorial nature of neurodegenerative diseases, a preventive strategy able to simultaneously target multiple risk factors and disease mechanisms at an early stage is most likely to be effective to slow/halt the progression of neurodegenerative diseases.

5 February 2015 in Developmental Cell
Verified
Journal Article
Closed access
EREmma Ristori
Emma Ristori
MLMiguel Alejandro Lopez-Ramirez
Miguel Alejandro Lopez-Ramirez
ANAnand Narayanan
Anand Narayanan
GHGuillermina Hill-Teran
Guillermina Hill-Teran
AMAlbertomaria Moro
Albertomaria Moro
SNStefania Nicoli
Stefania Nicoli

30 August 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ANAnand Narayanan
Anand Narayanan
GHGuillermina Hill-Teran
Guillermina Hill-Teran
AMAlbertomaria Moro
Albertomaria Moro
EREmma Ristori
Emma Ristori
DKDionna M. Kasper
Dionna M. Kasper
SNStefania Nicoli
Stefania Nicoli
A large number of microRNAs (miRNAs) are grouped into families derived from the same phylogenetic ancestors. miRNAs within a family often share the same physiological functions despite differences in their primary sequences, secondary structures, or chromosomal locations. Consequently, the generation of animal models to analyze the activity of miRNA families is extremely challenging. Using zebrafish as a model system, we successfully provide experimental evidence that a large number of miRNAs can be simultaneously mutated to abrogate the activity of an entire miRNA family. We show that injection of the Cas9 nuclease and two, four, ten and up to twenty-four multiplexed single guide RNAs (sgRNAs) can induce mutations in 90% of the miRNA genomic sequences analyzed. We performed a survey of these 45 mutations in 10 miRNA genes, analyzing the impact of our mutagenesis strategy on the processing of each miRNA both computationally and in vivo. Our results offer an effective approach to mutate and study the activity of miRNA families and pave the way for further analysis on the function of complex miRNA families in higher multicellular organisms.

27 August 2020 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
EREmma Ristori
Emma Ristori
SDSandra Donnini
Sandra Donnini
MZMarina Ziche
Marina Ziche
Cerebrovascular homeostasis is maintained by the blood-brain barrier (BBB), a highly selective structure that separates the peripheral blood circulation from the brain and protects the central nervous system (CNS). Dysregulation of BBB function is the precursor of several neurodegenerative diseases including Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA), both related to β-amyloid (Aβ) accumulation and deposition. The origin of BBB dysfunction before and/or during CAA and AD onset is not known. Several studies raise the possibility that vascular dysfunction could be an early step in these diseases and could even precede significant Aβ deposition. Though accumulation of neuron-derived Aβ peptides is considered the primary influence driving AD and CAA pathogenesis, recent studies highlighted the importance of the physiological role of the β-amyloid precursor protein (APP) in endothelial cell homeostasis, suggesting a potential role of this protein in maintaining vascular stability. In this review, we will discuss the physiological function of APP and its cleavage products in the vascular endothelium. We further suggest how loss of APP homeostatic regulation in the brain vasculature could lead toward pathological outcomes in neurodegenerative disorders.